Related Experiment Video
Updated: Aug 18, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using
Sridhar Radhakrishnan1, Oskar Hoff1, Markus K Muellner1
1Celeris Therapeutics, Inc., Menlo Park, CA 94025, USA.
Abstract:
Bivalent proximity-inducing compounds represent a novel class of small molecule therapeutics with exciting potential and new challenges. The most prominent examples of such compounds are utilized in targeted protein degradation where E3 ligases are hijacked to recruit a substrate protein to the proteasome via ubiquitination. In this review we provide an overview of the current state of E3 ligases used in targeted protein degradation, their respective ligands as well as challenges and opportunities that present themselves with these compounds.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome Structure
The proteasome is an...
Export of Misfolded Proteins out of the ER
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

